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Objective: 
The safety and effectiveness of a medical decision support system controlling stress hyperglycemia 
(Glucosafe), was tested prospectively in a medico-surgical intensive care unit (ICU) with a heterogeneous 
patient population. Using penalty functions for insulin and blood glucose, Glucosafe balances insulin 
treatment against glycemic outcome. 
 
Method:   
Insulin treatment was provided according to the local usual insulin algorithm (days 1 and 3) or according to 
Glucosafe (day 2) to reach the target range of 90-150 mg/dl. Nutrition was provided according to 
departmental guidelines. After the first 6 patients penalty functions were adapted by increasing target blood 
glucose from 99±10% to 104±10% mg/dl and increasing the penalty for high insulin doses. 
 
Results :  
Glucosafe was tested on 13 patients (age: 69.8±11.1; SAPS II: 44 ± 16). The use of Glucosafe reduced both 
the intrapatient  mean  and SD of  blood glucose significantly on day 2 (mean: 104 ± 7 mg/dl;N=98) relative 
to both day 1 (mean: 140 ± 11 mg/dl; N = 90, p<0.0005) and day 3 (mean: 116 ± 10 mg/dl; N = 60, p<0.005). 
Hypoglycemia (< 60 mg/dl) was not observed on any day.  
On day 2 (Glucosafe) 78% of measurements were in the target range compared to 67% on day 1 and 74% on 
day 3.   
On average insulin doses for days 1 and 3 combined were 2,08 units/h. Glucosafe used higher average 
insulin doses (3.62 and 2.4 units/h) before and after the adaptation of the penalty function. There was no 
significant difference in glycemia before and after the adaptation. 
 
Conclusion:  
Using Glucosafe with penalty functions adapted to the local environment safely improved the performance 
of glycemic control. 
